|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 67.85 EUR | +0.15% |
|
+0.22% | +99.56% |
| Apr. 11 | Health Care Slips on Risk Bias -- Health Care Roundup | DJ |
| Apr. 11 | Trending : Novartis Begins Tender Offer for MorphoSys Shares | DJ |
MorphoSys AG reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was EUR 238.28 million compared to EUR 278.27 million a year ago. Net loss was EUR 189.73 million compared to EUR 151.06 million a year ago.
Basic loss per share from continuing operations was EUR 5.53 compared to EUR 4.42 a year ago. Diluted loss per share from continuing operations was EUR 5.53 compared to EUR 4.42 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +99.56% | 2.73B | |
| +1.51% | 42.75B | |
| +8.57% | 41.34B | |
| +49.22% | 41.61B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
MORPHOSYS AG 
